Spain May Set Further Restrictions on The Sale and Distribution of Vapes

RegulationsMarket
Jul.05.2022
The Ministry of Health is looking into banning online sales of vaping products, and limit sales to specialized tobacco shops.

The Royal Decree 579/2017, is the legislation pertaining to the manufacture, advertising and sale of vaping products in Spain. The decree basically translates the Tobacco Products Directive (TPD) into Spanish regulations, and has been effective since the 11th of June 2017.

Spain May Set Further Restrictions on The Sale and Distribution of Vapes

And now, says Euro Weekly, the Spanish Government has set out to put further restrictions on the sale and distribution of e-cigarettes, with the Ministry of Health saying that they aim to reformulate the local anti-smoking legislation and extend it to the use of e-cigarettes, as they cause “harmful short-term effects”.

 

Led by Carolina Darias, the ministry said they are concerned about the sale of the devices, as “there is a large number of websites where nicotine-based devices can be bought online, and the methods for preventing access to minors are neither sufficient nor effective.” To this effect, they are looking into banning online sales of vaping products, and limit sales to specialised tobacco shops.

 

A general e-liquid tax is proposed

 

Similarly last year, Spain’s Ministry of Finance said it wanted to tighten the tobacco regulatory framework, so as to be in line with WHO and EU TPD standards. The umbrella organisation- the National Committee for the Prevention of Smoking (Comité Nacional para la Prevención del Tabaquismo (CNPT) had prepared a report for the Ministry of Health suggesting an excise duty based on both volume of e-liquid and nicotine content.

 

The report proposed a general e-liquid tax at the EU average rate of €0.15 per ml, with an additional element for nicotine content at €0.006 per mg. The group said that with an average tax rate of 35.6%, the Spanish government could collect €35m in revenue a year from the tax. “This is a viable option for the Spanish economy,” said a CNPT spokesperson to ECigIntelligence. “The government would obtain an economic return, while at the same time promoting a reduction in the consumption of these products.”

 

Commenting on the proposed tax, ECigIntelligence has recently highlighted that if the Spanish government indeed agrees to the tax, the local vape industry would be deeply impacted. The agency believes that the CNPT’s proposal is currently being discussed internally between the Ministry of Health and the Ministry of Finance.

 

The content excerpted or reproduced in this article comes from a third-party, and the copyright belongs to the original media and author. If any infringement is found, please contact us to delete it. Any entity or individual wishing to forward the information, please contact the author and refrain from forwarding directly from here.

Special Report | Can Nicotine Be Replaced? 6-MN Is Already on the Market While Key Human Evidence Is Still Missing
Special Report | Can Nicotine Be Replaced? 6-MN Is Already on the Market While Key Human Evidence Is Still Missing
Nicotine analogues such as 6-methylnicotine are already appearing in e-cigarettes and oral pouches, even as key human evidence remains limited. A new Nixodine-S study adds nonclinical data showing differences from nicotine in cytotoxicity and receptor activity, while independent studies point to a more complex toxicological picture. With supply-chain activity growing and FDA seeking clearer authority over nicotine analogues, the industry now faces a larger question: what evidence is needed before these substances can credibly replace nicotine?
SCIENCE
Sep.23
JUUL Purchasers Ask Ninth Circuit to Preserve Antitrust Classes in Case Over Altria’s $12.8 Billion Investment
JUUL Purchasers Ask Ninth Circuit to Preserve Antitrust Classes in Case Over Altria’s $12.8 Billion Investment
Private antitrust litigation stemming from Altria's 2018 $12.8 billion investment for a 35% economic interest in JUUL is advancing before the U.S. Court of Appeals for the Ninth Circuit. Direct purchasers, indirect purchasers and indirect resellers of JUUL products filed answering briefs this week seeking to preserve class certifications granted by a California federal court in February. Altria and JUUL argue that individual consumers and large distributors differ too much in purchasing terms to remain in a single direct-purchaser class, while a separate dispute concerns whether California antitrust law can apply to indirect purchasers across 27 jurisdictions. A September trial has been put on hold during the appeal.
Sep.23
JTI Invests ₱2.1 Billion to Upgrade Batangas Manufacturing Hub, Adds First Southeast Asia DIET Facility
JTI Invests ₱2.1 Billion to Upgrade Batangas Manufacturing Hub, Adds First Southeast Asia DIET Facility
JTI Asia Manufacturing Corp. has invested ₱2.1 billion, or about $37 million, in its manufacturing site in Malvar, Batangas, Philippines, to expand tobacco-processing capabilities. About ₱1.9 billion is allocated to JTI's first Dry Ice Expanded Tobacco, or DIET, facility in Southeast Asia, while more than ₱177 million has been spent on expanding its Controlled Atmosphere treatment facility. The Batangas plant supplies the Philippine market and exports to 22 overseas markets, making it one of JTI's key manufacturing hubs in Asia.
Sep.24
On-Site Report | After FDA Announces Review of PMTA Framework, CTP Director Details Reform Priorities
On-Site Report | After FDA Announces Review of PMTA Framework, CTP Director Details Reform Priorities
FDA CTP Director Bret Koplow used his FDLI keynote in Washington to outline how the agency is rethinking the PMTA framework. He discussed category-specific review, nicotine pouch and sPMTA pilots, AI-assisted review, a 70% reduction in pending applications, and a major staffing constraint: CTP currently has only nine scientific review teams. He also reaffirmed tobacco harm reduction while stressing youth protection, flavored products, risk communication, and the challenge of unauthorized e-cigarettes.
Regulations
Oct.06
NAS 2026 | Cliff Douglas: Risk Continuum Should Play a Central Role in Tobacco Policy
NAS 2026 | Cliff Douglas: Risk Continuum Should Play a Central Role in Tobacco Policy
Cliff Douglas, a veteran U.S. tobacco-control and public health policy figure, told NAS 2026 that the “continuum of risk” should play a central role in tobacco policy. He called for clearer market pathways, stronger risk communication, differentiated regulation and enforcement, and said possible FDA reforms to PMTA reviews could be a “welcome correction” if they create a more efficient, predictable route for scientifically substantiated lower-risk products. Read 2Firsts’ on-site coverage.
Sep.26
2Firsts Interview | Cigarette Sales Fall as Smokeless Alternatives Gain in U.S. Convenience Stores, NACS Says
2Firsts Interview | Cigarette Sales Fall as Smokeless Alternatives Gain in U.S. Convenience Stores, NACS Says
Ahead of the 2026 NACS Show, 2Firsts interviewed Chris Rapanick, NACS managing director of research, on changes reshaping the U.S. convenience-store tobacco and nicotine market. NACS data show cigarette sales declining while smokeless alternatives, including nicotine pouches, continue to grow. The interview also examines higher OTP margins, shifting backbar space, weaker store traffic, regulatory uncertainty and NACS’ outlook for 2027, offering a retailer-side view of one of the world’s largest nicotine markets.
Interview
Oct.03